发明授权
US3891761A N-Methyl-d-glucamine salt of 2(2-methyl-3{40 -trifluoro-methylanilino) nicotinic acid in the treatment of pain
失效
2(2-甲基-3 {40-三氟 - 甲基苯胺基)烟酸的N-甲基-d-葡糖胺盐治疗疼痛
- 专利标题: N-Methyl-d-glucamine salt of 2(2-methyl-3{40 -trifluoro-methylanilino) nicotinic acid in the treatment of pain
- 专利标题(中): 2(2-甲基-3 {40-三氟 - 甲基苯胺基)烟酸的N-甲基-d-葡糖胺盐治疗疼痛
-
申请号: US45892074申请日: 1974-04-08
-
公开(公告)号: US3891761A公开(公告)日: 1975-06-24
- 发明人: SHERLOCK MARGARET H
- 申请人: SCHERING CORP
- 专利权人: Merck Sharp & Dohme Corp
- 当前专利权人: Merck Sharp & Dohme Corp
- 优先权: US45892074 1974-04-08; US34560873 1973-03-28
- 主分类号: A61K27/00
- IPC分类号: A61K27/00
摘要:
This invention relates to the N-methyl-D-glucamine salt of 2(2''-methyl-3''-trifluoromethylanilino) nicotinic acid and to its particular suitability as a parenterally administered analgesic agent.
信息查询